Home > Insider Trading > Filing (0001209191-21-007946)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
906709	Nektar Therapeutics	NKTR	Pharmaceutical Preparations (2834)	943134940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1808356	Andrew Mark Wilson	C/O Nektar Therapeutics 455 Mission Bay Blvd South, Suite 100 San Francisco CA 94158	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-02-03	5,344	$8.80	84,244	No	4	M	Direct
Common Stock	Disposition	2021-02-03	5,344	$19.45	78,900	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2021-02-03	5,344	$0.00	5,344	$8.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-02-06	2021-02-05	No	4	M	Direct

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This number includes 3,107 shares held by the reporting person in his account under the Issuer's ESPP Plan. The acquisition of these shares under that plan is exempt under Rule 16b-3(c).
This transaction was executed in multiple trades at prices ranging from $19.30 to $19.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.